NSETrading Window24 Jun 2026 · 24 Jun 2026, 05:46 pm
Trading Window
ORTIN GLOBAL LIMITED · ORTINGLOBE
✦ AI Summary
ORTIN GLOBAL LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from 01.07.2026 till 48 hours after the declaration of Unaudited Financial Results for the Quarter ending 30.06.2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
ORTIN GLOBAL LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
ORTINLAB_24062026174618_Closure_of_Trading_Window_SD.pdf
View document text
ORTIN GLOBAL LIMITED
(Formerly Known as ORTIN LABORATORIES LIMITED)
CIN: L68200TG1986PLC006885
To, Date: 24.06.2026
The Manager The Manager
BSE Limited NSE Limited,
P.J. Towers, Dalal Street Exchange Plaza, Bandra-Kurla Complex,
Mumbai- 400001 Mumbai 400051
(BSE Scrip Code: 539287) (NSE Symbol: ORTINGLOBE)
Dear Sir/Madam,
Sub: Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015
Unit: Ortin Global Limited (formerly known as Ortin Laboratories Limited)
With reference to the subject cited and pursuant to the Company’s Code of Conduct for Prevention of
Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015
the trading window for dealing in the securities of the Company will remain closed from 01.07.2026 till
48 hours after the declaration of Unaudited Financial Results for the Quarter ending 30.06.2026 for all
designated persons, their immediate relatives and all connected persons covered under the Company’s
Code of Conduct.
The Board Meeting will be scheduled, inter-alia, to consider and approve the Unaudited Financial Results
for the quarter ending June 30, 2026. Accordingly, an intimation regarding the notice of Board Meeting
shall be sent separately to the Stock Exchange. Further, the designated persons have been intimated not to
trade in the securities of the Company during the above said period of closure of trading window.
This is for the information and records of the Exchange, please.
Thanking you.
Yours sincerely,
For Ortin Global Limited
(formerly known as Ortin Laboratories Limited)
S. Murali Krishna Murthy
Managing Director
DIN: 00540632
Regd. Office: D. No. l-8-305, Ground Floor, Chikkadpally, Musheerabad (Delivery),
Hyderabad-500020, Telangana, India.
Email:info@ortinlabsindia.com Website:www.ortinlabsindia.com
Ph. No. +91 9052011118